Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
deal
Pharma
Ascendis pays 20% royalties in patent settlement with BioMarin
The two pharmas sidestepped significant legal overhang with a licensing deal that analysts are calling mutually beneficial.
Donavyn Coffey
Aug 31, 2026 1:56pm
Fierce Biotech
China biotechs ‘reshaping’ US biopharma: Jefferies report
Jul 14, 2025 2:30pm
Ratio inks deal to build radiopharma production facility in Utah
May 13, 2025 10:07am
England's Abcam weighs its options, which could include a sale
Jun 29, 2023 8:05am
Sanofi is offloading 17 meds from its pain and CNS rosters
Jul 12, 2022 9:13am
Collaboration in biopharma is 'alive and well,' panel says
Jan 19, 2022 11:15am